跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24,041 条关于
“HPV-negative HNSCC”
全部
24,041
临床试验
19,827
药物
843
机构
14
资讯
3,357
去年
Novel Chemo-Immunotherapy Approach Shows Promise for Advanced HPV-Negative Head and Neck Cancer
去年
Bicara Launches Pivotal Phase 2/3 Trial of Novel Bifunctional Antibody for Advanced Head and Neck Cancer
11个月前
Bicara Therapeutics Receives FDA Breakthrough Therapy Designation for Head and Neck Cancer Treatment
去年
Spatial Transcriptomics Reveals New Therapeutic Targets for Head and Neck Cancer Immunotherapy
2年前
Bicara, Zenas, and MBX Bio Launch IPOs, Raising $703M for Clinical Trials
去年
Aprea Therapeutics Advances APR-1051 Clinical Trial with First HPV+ Head and Neck Cancer Patient Dosed
2年前
PDS Biotech's Versamune HPV Plus Keytruda Shows Promising Results in HPV16-Positive Head and Neck Cancer
去年
BNT113 Cancer Vaccine Shows Promise in Phase II/III Trial for HPV16+ Head and Neck Cancer
去年
Genomically Distinct Subclass of Head and Neck Cancer Identified
2年前
PDS Biotech's Versamune® HPV Shows Promising Results in Head and Neck Cancer Trial
第 1 页,共 336 页
上一页
下一页